Detalles de la búsqueda
1.
A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers.
Br J Clin Pharmacol
; 88(3): 1063-1073, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34374114
2.
Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial.
Clin Transl Sci
; 14(5): 1756-1768, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33834628
3.
Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
AAPS J
; 22(6): 134, 2020 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33070288
4.
A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects.
Clin Drug Investig
; 40(5): 433-447, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32222912
5.
In-Vivo Degradation of DNA-Based Therapeutic BC 007 in Humans.
Eur J Drug Metab Pharmacokinet
; 44(4): 567-578, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30674038
Resultados
1 -
5
de 5
1
Próxima >
>>